Latest Share Chat

REMOVE ADS

Hikma Pharmaceuticals Share News (HIK)

Hikma Pharmaceuticals Information

Share Price Information for Hikma Pharmaceuticals (HIK)

Share Price is delayed by 15 minutes

Get Live Data

1,531.00 1.00 (0.07%)

Bid:

1,531.00

Ask:

1,532.00

Spread: 1.00 (0.065%)

Market Cap: £3.22b

Last checked at -

Intraday Hikma Pharmaceuticals Share Chart

REMOVE ADS

Hikma Pharmaceuticals News

Hikma Pharmaceuticals plans USD1 billion investment to support US unit

(Alliance News) - Hikma Pharmaceuticals PLC has pledged to invest USD1 billion by 2030 to further expand its US manufacturing and R&D capabilities.

LONDON MARKET CLOSE: FTSE 100 up; pound hits near four-year high

(Alliance News) - Miners and defence stocks helped support the FTSE 100 on Thursday, shaking off a stronger pound, which serves as a headwind for the ...

LONDON MARKET CLOSE: Stocks mixed amid GDP miss and fresh trade worry

(Alliance News) - The FTSE 100 closed higher on Thursday, despite weak UK growth figures and renewed geopolitical tensions and tariff worries.

DIRECTOR DEALINGS: Hikma exec and AB Dynamics advisor sell shares

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced so far this week and not sep...

LONDON BROKER RATINGS: Aviva and Dunelm cut, M&G raised

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday:

LONDON MARKET CLOSE: FTSE 100 pushes above 8,800 amid services rebound

(Alliance News) - Stocks in London made healthy progress on Wednesday, shrugging off weak US data, after a survey showed the UK services sector return...

LONDON BROKER RATINGS: Jefferies raises Hiscox, cuts Rio Tinto

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday:

IN BRIEF: Fitch follows S&P in raising Hikma Pharmaceuticals to BBB

Hikma Pharmaceuticals PLC - London-based drug maker with operations in Jordan - Notes that credit rating firm Fitch has upgraded Hikma's long-term iss...